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a  b  s  t  r  a  c  t
This study aimed to evaluate the in vitro antifungal activity of terpinen-4-ol, tyrosol, and
-lapachone against strains of Coccidioides posadasii in ﬁlamentous phase (n = 22) and Histo-
plasma capsulatum in both ﬁlamentous (n = 40) and yeast phases (n = 13), using the broth
dilution methods as described by the Clinical and Laboratory Standards Institute, to deter-
mine the minimum inhibitory concentration (MIC) and minimum fungicidal concentration
(MFC) of these compounds. The mechanisms of action of these compounds were also
investigated by analyzing their effect on cell membrane permeability and ergosterol syn-
thesis. The MIC and MFCf these compounds against C. posadasii, mycelial H. capsulatum,
and  yeast-like H. capsulatum,  were in the following ranges: 350–5720 g/mL, 20–2860 g/mL,
and  40–1420 g/mL, respectively for terpinen-4-ol; 250–4000 g/mL, 30–2000 g/mL,
and  10–1000 g/mL, respectively, for tyrosol; and 0.48–7.8 g/mL, 0.25–16 g/mL, and
0.125–4 g/mL, respectively for -lapachone. These compounds showed a decrease in MIC
when the samples were subjected to osmotic stress, suggesting that the compounds acted
on  the fungal membrane. All the compounds were able to reduce the ergosterol content of
the  fungal strains. Finally, tyrosol was able to cause a leakage of intracellular molecules.©  2016 Sociedade Bras
an  open access arti
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Introduction
Coccidioidomycosis and histoplasmosis are systemic mycoses
reported in the Americas, especially in the United States, Mex-
ico, and Brazil. These diseases are caused by the dimorphic
fungi Coccidioides spp. and Histoplasma capsulatum var. capsula-
tum, respectively. In Brazil, coccidioidomycosis caused by the
species C. posadasii has only been reported in the Northeast,
while histoplasmosis has been reported throughout the coun-
try with a 40% lethality rate when associated with AIDS.1,2
The treatment of these diseases involves azoles in cases with
mild to moderate symptoms and amphotericin B in severe
cases.3,4 Although the standard antifungal therapies are effec-
tive for treating these mycoses, some disadvantages have been
observed for these therapies, such as nephrotoxicity caused
by amphotericin B,5 the high cost of the lipid formulations of
amphotericin B,6 and the fact that only 50–60% of patients with
coccidioidomycosis respond to the treatment with ﬂuconazole
and itraconazole7 and 56–70% of patients with histoplasmosis
respond to the treatment with ketoconazole.8 Hence, a search
for new therapeutic strategies against these pathogens is of
great importance.
Terpinen-4-ol is a terpene alcohol that exhibits in vitro
antifungal properties against Candida spp., Cryptococcus neo-
formans, Malassezia spp., Rhodotorula spp., Trichosporon spp.,
Aspergillus spp., Penicillium spp., and dermatophytes.9–12
Tyrosol is a phenolic compound with antioxidant proper-
ties and an autoregulatory molecule of C. albicans13,14 which
has in vitro antifungal properties against Candida spp.15
-Lapachone is a quinone derived from lapachol with antifun-
gal properties against Candida spp., Cryptococcus neoformans,
and dermatophytes.16–19 In the light of the earlier studies,
this investigation aimed at evaluating the in vitro inhibitory
effects of these compounds and investigating the mecha-
nism of action of these compounds against the fungal strains,
C. posadasii and H. capsulatum.
Materials  and  methods
Microorganisms
Twenty-two strains of C. posadasii in the ﬁlamentous phase
(18 clinical, 3 environmental, and 1 animal) and 40 strains
of H. capsulatum in the ﬁlamentous stage (38 clinical and 2
animal) were used for this study. Among the H. capsulatum
strains, 13 were also evaluated in the yeast phase. All the fun-
gal strains were obtained from the fungal collection of the
Specialized Medical Mycology Center (CEMM, Federal Univer-
sity of Ceará, Brazil). The procedures for identiﬁcation of the
fungi included the classic mycological analysis, as described
by Brilhante et al.20 All the procedures were performed in a
class II biological safety cabinet in a biosafety level 3 labora-
tory.Antimicrobial  agents
For the assays, terpinen-4-ol, tyrosol, and -lapachone (all
from Sigma Chemical Corporation, USA) were used. The b i o l o g y 4 7 (2 0 1 6) 917–924
traditional antifungal drugs, amphotericin B (AMB) (Sigma
Chemical Corporation, USA) and itraconazole (ITC) (Janssen
Pharmaceutica, Belgium) were used as control drugs. The
stock solutions of terpinen-4-ol, ITC, and AMB  were pre-
pared in 100% dimethyl sulfoxide (DMSO); -lapachone was
dissolved in 80% DMSO; and tyrosol was dissolved in ster-
ile distilled water.15,21,22 All the stock solutions were stored
at −20 ◦C until use. Serial dilutions of each compound were
prepared in RPMI 1640 medium (Sigma Chemical Corpora-
tion, USA), supplemented with l-glutamine, buffered to pH
7.0 using 0.156 M MOPS (Sigma Chemical Corporation, USA).
DMSO was included in the assays as control to conﬁrm that
the DMSO used to dilute the compounds did not interfere with
fungal growth.20
Preparation  of  inoculum  for  antifungal  susceptibility
assays
The strains of C. posadasii were grown on potato agar and incu-
bated for 7 days at room temperature (25–28 ◦C). To prepare the
inoculum, 2 mL  of sterile saline were added to each culture,
and the surface of the mycelium was scraped with a micro-
biological loop. The suspensions were transferred to sterile
tubes and allowed to stand for 5 min. The supernatant was
read in a spectrophotometer at a wavelength of 530 nm,  and
its transmittance was set to 95%. The suspensions contain-
ing arthroconidia and hyphal fragments were diluted to 1:10
with RPMI 1640 medium to obtain inocula containing approx-
imately 1 × 103–5 × 103 CFU/mL.20
H. capsulatum strains in ﬁlamentous form were grown on
brain heart infusion (BHI) agar (Himedia, India) at 28 ◦C for 7
days. The inoculum was prepared as described earlier. H. cap-
sulatum strains in the yeast phase were grown in Sabouraud
agar or BHI agar supplemented with 10% sheep blood and incu-
bated for 7 days at 35 ◦C. Then, an aliquot of the fungal colony
was transferred to 2 mL  of sterile saline. The absorbance of
supernatant was measured in a spectrophotometer at a wave-
length of 530 nm,  and its transmittance was set to 95%. The
suspensions containing arthroconidia and hyphal fragments
were diluted to 1:10 with RPMI 1640 medium to obtain inocula
containing approximately 1 × 103–5 × 103 CFU/mL.20
Antifungal  susceptibility  test
The susceptibility of C. posadasii strains to the com-
pounds being tested was determined through the broth
macrodilution method, according to the M38-A2 protocol
standardized by the CLSI.23 The susceptibility of H. cap-
sulatum to the compounds was determined by the broth
microdilution method, according to the M27-A3 protocol
standardized by the CLSI.24 The concentrations of the
tested compounds for C. posadasii strains were as follows:
Terpinen-4-ol (350–5720 g/mL), tyrosol (250–4000 g/mL),
-lapachone (0.48–7.8 g/mL), AMB  (0.0625–1 g/mL), and
ITC (0.0625–1 g/mL). The concentrations of the com-
pounds being tested against H. capsulatum strains (in both
phases) were as follows: Terpinen-4-ol (10–5720 g/mL),
tyrosol (3.9–2000 g/mL), -lapachone (0.0312–16 g/mL), AMB
(0.0039–2 g/mL), and ITC (0.00195–1 g/mL).
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The MIC  for AMB  was deﬁned as the lowest concentration
f drug capable of inhibiting 100% of fungal growth, while for
he other compounds, MICs were deﬁned as the lowest con-
entration of compounds capable of inhibiting 80% of fungal
rowth, when compared to the drug-free growth control.20 All
he tests were performed in duplicate. The results obtained
ere visually examined after 48 h (for C. posadasii), 4 days (for
. capsulatum in the yeast phase), and 7 days (for H. capsu-
atum in the ﬁlamentous phase) of incubation at 35 ◦C. For
uality control of the antifungal susceptibility tests, Candida
arapsilosis ATCC 22019 and Candida krusei ATCC 6258 were
ncluded.20
The minimum fungicidal concentration (MFC) of the com-
ounds against C. posadasii and H. capsulatum was deﬁned
s the lowest concentration that completely inhibited fungal
rowth, after seeding 100 L of the fungal suspension, at con-
entrations of compound just above the MIC, on potato agar
nd incubating for 6–7 days at 35 ◦C.
nhibitory  effect  of  the  compounds  under  osmotic  stress
he ability of the compounds to alter the permeability of the
ungal membrane was also evaluated by macrodilution and
icrodilution. The assay was performed with 12 strains of
. posadasii (ﬁlamentous phase), 8 strains of H. capsulatum (ﬁl-
mentous phase), and 8 strains of H. capsulatum (yeast phase).
smotic stress was induced by adding 0.1 M NaCl to RPMI
640 medium (pH 7.0) as described by Brilhante et al.1 The
ompounds were used below inhibitory concentrations. The
esults were visually determined at the end of the above men-
ioned incubation period at 35 ◦C.1 The concentration of NaCl
ncorporated into RPMI broth was determined based on the
esults of susceptibility of fungal strain to salt, in which con-
entrations ≤0.175 M did not interfere with fungal growth for
oth species compared with the drug-free and salt-free growth
ontrol.
ffect  of  the  compounds  on  cell  membrane  permeability
his test was performed, in order to determine the ability
f these compounds to alter the permeability of the fun-
al membrane, causing leakage of intracellular molecules, as
escribed by Cordeiro et al.2 Ten strains of C. posadasii (ﬁla-
entous phase), eight strains each of the ﬁlamentous phase
nd yeast phase of H. capsulatum were used. These strains were
xposed to different concentrations (MIC and MIC/2) of the
ompounds as previously determined in the macrodilution
nd microdilution assays. Growth control (without drugs) and
lank solution (culture medium control) were also included in
he tests. AMB  (negative control) and isoniazid (positive con-
rol) were used as the controls.2 One milliliter from each tube
ontaining the fungal inoculum exposed to the compound
as transferred to sterile microcentrifuge tubes and cen-
rifuged for 15 min  (13,400 × g). Of the supernatant, 70 L was
emoved from each tube and diluted 1:10 in sterile distilled
ater. The release of UV-absorbing molecules was analyzed
y spectrometry at 260 nm for nucleic acids and 280 nm for
roteins.o l o g y 4 7 (2 0 1 6) 917–924 919
Ergosterol  quantiﬁcation
Cellular ergosterol was quantiﬁed as described by Brilhante
et al.1 The extraction was performed using ten strains of
C. posadasii strains (ﬁlamentous phase), eight strains each
of the ﬁlamentous phase and yeast phase of H. capsula-
tum. Ergosterol was extracted after the exposure of the
strains to inhibitory and subinhibitory concentrations of
the compounds being tested, itraconazole (positive control
drug), and amphotericin B (negative control drug), using
macrodilution and microdilution techniques. Six different
concentrations of the compounds were tested. The ranges
of concentration tested against C. posadasii were as fol-
lows: Terpinen-4-ol (10–1420 g/mL), tyrosol (15–2000 g/mL),
-lapachone (0.03–3.9 g/mL), AMB  (0.003–0.5 g/mL), and
ITC (0.003–0.5 g/mL). The ranges of concentration tested
against H. capsulatum (in both phases) were as fol-
lows: Terpinen-4-ol (0.6–350 g/mL), tyrosol (0.4–500 g/mL),
-lapachone (0.003–1 g/mL), AMB (0.001–1 g/mL), and ITC
(0.00006–0.5 g/mL). The fungal pellet for each concentration
was exposed to 0.5 mL  of 20% (w/v) KOH, 60% (v/v) EtOH solu-
tion and incubated at 95 ◦C for 1 h in a water bath. Then, 0.6 mL
of hexane was added to isolate the sterols. The solutions were
centrifuged for 5 min  (10,000 × g). Then, the top layer of hex-
ane was transferred to microtubes, and 0.5 mL  of hexane was
added. The quantiﬁcation of ergosterol was performed in a UV-
visible spectrophotometer at  = 295.10 nm and compared with
a predetermined standard curve. Ergosterol extracted from
the strains of C. posadasii and H. capsulatum grown in drug-
free RPMI medium was quantiﬁed and treated as a positive
control.1
Statistical  analysis
The results of the assays performed in this study were ana-
lyzed using the Student’s t-test and ANOVA, using the post
hoc Fisher’s LSD test. In all the cases, p < 0.05 was considered
statistically signiﬁcant.
Results
In  vitro  susceptibility  testing
The MICs and MFCs of the compounds determined against
C. posadasii were as follows: 350 ≤ MIC  ≤ 1420 g/mL and
1420 ≤ MFC  ≤ 5720 g/mL for terpinen-4-ol; 250 ≤ MIC
≤ 2000 g/mL and 1000 ≤ MFC ≤ 4000 g/mL for tyrosol;
and 0.48 ≤ CIM ≤ 3.9 g/mL and 1.95 ≤ MFC  ≤ 7.8 g/mL for
-lapachone (Table 1).
The MICs and MFCs determined against H. capsulatum in
the ﬁlamentous phase were as follows: 20 ≤ MIC  ≤ 1420 g/mL
and 170 ≤ MFC ≤ 2860 g/mL for terpinen-4-ol; 30 ≤ MIC
≤ 1000 g/mL and 60 ≤ MFC ≤ 2000 g/mL for tyrosol;
and 0.25 ≤ MIC ≤ 1 g/mL and 0.5 ≤ MFC  ≤ 16 g/mL for
-lapachone (Table 1).
For H. capsulatum in the yeast phase, the following
MICs and MFCs were obtained: 40 ≤ MIC ≤ 350 g/mL
and 170 ≤ MFC  ≤ 1420 g/mL for terpinen-4-ol; 10 ≤ MIC  ≤
920  b r a z i l i a n j o u r n a l o f m i c r o b i o l o g y 4 7 (2 0 1 6) 917–924
Table 1 – Minimum inhibitory and minimum fungicidal concentrations for terpinen-4-ol, tyrosol, -lapachone and
control drugs against C. posadasii and H. capsulatum strains.
Species n Drugs (g/mL)
Terpinen-4-ol Tyrosol -Lapachone AMB ITC
MIC MFC MIC MFC MIC MFC MIC (range) MIC (range)
H. capsulatum (F) 40 20  (7)a 170 (3) 31.2 (3) 62.5 (1) 0.25 (6) 0.5 (1) 0.0078–0.5 0.0039–0.0312
40 (13) 350 (18) 62.5 (1) 250 (3) 0.5 (11) 1 (2)
80 (8) 710 (10) 125 (5) 500 (7) 1 (20) 2 (14)
170 (3) 1420 (6) 250 (10) 1000 (16) 2 (3) 4 (17)
710 (6) 2860 (3) 500 (19) 2000 (13) 8 (4)
1420 (3) 1000 (2) 16 (2)
H. capsulatum (Y) 13 40  (1) 170 (2) 15.6 (2) 62.5 (1) 0.125 (1) 1 (1) 0.0625–0.5 0.0039–0.0312
80 (3) 350 (2) 62.5 (1) 125 (1) 0.25 (4) 2 (5)
170 (4) 710 (4) 125 (8) 250 (1) 0.5 (6) 4 (7)
350 (5) 1420 (5) 250 (2) 500 (2) 1 (2)
1000 (8)
C. posadasii (F) 22 350  (6) 1420 (2) 250 (3) 1000 (1) 0.48 (1) 1.95 (1) 0.0625–0.5 0.125–0.5
710 (12) 2860 (11) 500 (10) 2000 (2) 0.97 (9) 7.8 (21)
1420 (4) 5720 (9) 1000 (7) 4000 (19) 1.95 (8)
2000 (2) 3.9 (4)
um 
TC, itF, ﬁlamentous phase; Y, yeast phase; n, number of strains; MIC, Minim
a Number of strains for each MIC/MFC value; AMB, amphotericin B; I
250 g/mL and 60 ≤ MFC  ≤ 1000 g/mL for tyrosol, and
0.125 ≤ MIC  ≤ 1 g/mL and 1 ≤ MFC  ≤ 4 g/mL for -lapachone.
The MIC  values determined for the control drugs (AMB
and ITC) were in agreement with the intervals found in previ-
ous tests against C. posadasii and H. capsulatum (Table 1). The
standard strains, C. parapsilosis and C. krusei used as control
exhibited MIC  values for AMB  and ITC that were in agreement
with CLSI guidelines.
Osmotic  stress
The MICs determined for the compounds tested with
RPMI + NaCl were statistically lower than those obtained using
the standard RPMI against C. posadasii and H. capsulatum
strains. There was a signiﬁcant reduction in the range of 4–64
times in the MIC  values of terpinen-4-ol (p = 0.0000), tyrosol
(p = 0.0001), and -lapachone (p = 0.0012) and the control drug,
ITC (p = 0.0003) (Table 2).
Cell  membrane  permeability
The results showed that despite the possible effects of all the
compounds on the permeability of the fungal membrane, only
tyrosol was able to cause leakage of intracellular molecules
in C. posadasii and H. capsulatum strains. Tyrosol caused the
leakage of nucleic acids leading to a signiﬁcant increase in
absorbance at 260 nm,  reaching values signiﬁcantly higher
than those obtained for the fungal growth control (p = 0.0000)
and the control drug AMB  (negative control) (p = 0.0000), but
similar to the absorbance values obtained for isoniazid (pos-
itive control) (p > 0.05) at MIC  and MIC/2 (Fig. 1). Tyrosol also
caused leakage of proteins with absorbance values (at 280 nm)
signiﬁcantly higher than those obtained for the fungal growth
control (p = 0.0000), the control drug AMB  (negative control)
(p = 0.0000), but similar to the values obtained for the positive
control drug isoniazid (p = 0.0000) at MIC  and MIC/2 (Fig. 1). TheInhibitory Concentration; MFC, Minimum Fungicidal Concentration.
raconazole.
values obtained with other compounds at 260 nm and 280 nm
had no signiﬁcant differences, when compared to the fungal
growth control and AMB (p > 0.05), and were lower than those
of isoniazid (p = 0.0000), indicating no evidence of leakage of
molecules (Fig. 1).
Quantiﬁcation  of  ergosterol
The results showed that the exposure of strains of
C. posadasii and H. capsulatum to sub-inhibitory concentra-
tions of terpinen-4-ol, tyrosol, and -lapachone resulted in
a decrease in the amount of ergosterol extracted from fun-
gal cells compared to the fungal growth control (p = 0.0000)
(Fig. 2). Higher the concentration of the compounds, lower
is the amount of ergosterol extracted from the fungi. Simi-
lar results were observed for ITC (positive control), with no
signiﬁcant difference between the results obtained for the
compounds and the control drug, ITC (p > 0.05) (Fig. 2).
Discussion
The availability of a small number of antifungal drugs, the
associated side effects of amphotericin B (i.e., nephrotoxicity),
the high cost of the lipid formulations of amphotericin B,
and the possible failure of some individuals to respond to the
treatment with azoles may complicate the treatment of these
mycoses. Hence, there is an urgent need to ﬁnd new drugs
or compounds possessing antifungal properties.5–8,25 Several
studies have contributed to the development of new agents
and to expand the list of antifungal drugs, such as terpinen-
4-ol, tyrosol, and -lapachone. The decision to include these
compounds in the present work was motivated by their
antimicrobial properties observed in other studies, especially
against some species of yeasts and ﬁlamentous fungi. In addi-
tion, there are no reports available on the effects of these
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Table 2 – MIC  values (mean) for terpinen-4-ol, tyrosol and -lapachone and the control drug itraconazole in the absence
and presence of osmotic stress against C. posadasii and H. capsulatum strains.
Species n Drugs (g/mL) – mean of MIC values
Terpinen-4-ol Tyrosol -Lapachone Itraconazole
RPMI RPMI + NaCl RPMI RPMI + NaCl RPMI RPMI + NaCl RPMI RPMI + NaCl
C. posadasii (F) 12 768 133 958 87 2 0.5 0.2 0.01
H. capsulatum (F) 8 65 9 253 32 0.6 0.1 0.1 0.009
H. capsulatum (Y) 8 176 22 89 9 0.4 0.06 0.02 0.001
F, ﬁlamentous phase; Y, yeast phase; n, number of strains; MIC, Minimum Inhibitory Concentration. Reduction of MIC values: Terpinen-4-ol
F
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Fig. 2 – Quantiﬁcation of ergosterol from the ten strains of
Coccidioides posadasii (2a), eight ﬁlamentous (F) strains of
Histoplasma capsulatum (2b), and eight yeast (Y) strain of H.
capsulatum (2c) after exposure to sub-inhibitory
concentrations of terpinen-4-ol (TER), tyrosol (TIR),
-lapachone (B-LAP), itraconazole (ITC, control drug), and
amphotericin B (AMB, control drug). These values represent
the average results for all strains tested for each species.
Control: fungal growth control without drug.
compounds against the dimorphic fungi, C. posadasii and
H. capsulatum.It was observed that the MIC  values obtained for terpinen-
4-ol against C. posadasii and the ﬁlamentous and yeast
phases of H. capsulatum were comparable to those reported by b i o l o g y 4 7 (2 0 1 6) 917–924
Hammer et al.9 against Candida spp., Saccharomyces cerevisiae,
Rhodotorula mucilaginosa, Trichosporon spp., Aspergillus spp.,
Penicillium spp., and dermatophytes of the genera, Trichophy-
ton,  Epidermophyton, and Microsporum (MIC = 0.008–0.25%) and
the ﬁndings of Marcos-Arias et al.15 against Candida spp.
(MIC = 0.06–0.5%).
In the case of tyrosol, the MIC values obtained against
C. posadasii and H. capsulatum in both the ﬁlamentous and
yeast phases showed concentrations lower than the levels
reported in literature, such as the ﬁndings of Marcos-Arias
et al.15 against Candida spp. (MIC = 0.5–8%).
In the case of -lapachone, the MIC values obtained against
C. posadasii and the ﬁlamentous and yeast phases of H. cap-
sulatum were similar to the data reported in other studies
with naphthoquinone derivatives, such as the ﬁndings of
López et al.17 against Candida spp., Cryptococcus neoformans,
and dermatophytes of the genera Trichophyton and Microsporum
(MICs = 0.5–64 g/mL).
It is possible that the tested compounds might exhibit a
fungicidal effect because their MIC  values are not much lower
than their MFCs. According to Vila et al.26 when MFC  values
are lower than four-times the MIC values, a fungicidal effect
is suggested, while a fungistatic effect is expected when MFC
values are higher than four-times the MIC values.
Ergosterol is the predominant lipid molecule found in yeast
cells. It regulates the ﬂuidity and permeability of the mem-
brane and the activity of many  enzymes incorporated into this
structure. Hence, it plays an important role in cell growth.27
Studies report that essential oils derived from plants and their
monoterpenoid components such as terpinen-4-ol, which is a
major component of the tea tree oil, have a lipophilic charac-
teristic, likely presenting a direct action on the cell membrane
structure and associated enzymes.10,15,27
It has been reported that terpenes cross the fungal cell wall
and are inserted between the fatty acid chains that consti-
tute the lipid bilayer membrane, causing changes in its ﬂuidity
and permeability. These alterations may lead to the degrada-
tion of the cell wall, reduction in adherence to host surfaces,
and other effects, such as the disruption of the plasma mem-
brane, loss of cell content, coagulation of cytoplasm, and cell
lysis.15 Cox et al.28 veriﬁed the capacity of tea tree oil and
its components to alter the integrity of the cell membrane
of Gram-negative bacteria and the yeast C. albicans. Parveen
et al.29 found that a monoterpene affects the ergosterol and
lipid biosynthesis and cell wall structure of Saccharomyces cere-
visiae, leading to speciﬁc changes in gene expression. The
results of the present study corroborates this report, by estab-
lishing the ability of terpinen-4-ol to inhibit the synthesis of
ergosterol on the tested dimorphic fungi, as shown by the
reduction in the amount of ergosterol extracted from fungal
cells after exposure to subinhibitory concentrations of this
compound.
Currently, little is known about the mechanism of action of
tyrosol on fungal cell, with no reports in the literature. How-
ever, this study was able to show the effect of tyrosol on the
permeability of the cell membrane of dimorphic fungi, includ-
ing the reduction of MIC values after the exposure of fungal
strains to high salinity. These ﬁndings suggest the degener-
ation of the cell membrane. In addition, tyrosol also caused
leakage of protein and nucleic acids, suggesting the effect of
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yrosol on both, cellular and nuclear membrane. The results
lso showed the property of tyrosol to inhibit the synthesis of
rgosterol, as demonstrated by the reduction in the amount
f ergosterol extracted from fungal strains after exposure to
igh concentrations of tyrosol.
The effect of -lapachone on the plasma membrane might
e due to its lipophilic nature, which may affect the metabolic
athways and functionalities of cellular processes.17 This fact
as corroborated in this study that shows that -lapachone
ffects the permeability of the cytoplasmic membrane of
. posadasii and H. capsulatum, indicating that the effect is
ssociated with the degeneration of the fungal membrane.
n addition, this compound interferes with the synthesis
f ergosterol, reducing the amount of ergosterol extracted
rom fungal cells after exposure to high concentrations of
-lapachone. This compound also has the ability to induce
xidative stress in eukaryotic cells by intracellular forma-
ion of reactive oxygen species, such as hydrogen peroxide
H2O2), the superoxide anion radical (O2−), and hydroxyl radi-
al (OH), inducing apoptosis and cytotoxicity.16,22,29 Moreover,
-lapachone causes inhibition of the topoisomerase I and II
n both prokaryotic and eukaryotic cells, which are impor-
ant for the normal cellular operation, since they maintain
he integrity of DNA. It is a well established fact that any
unctional alterations in these enzymes is sufﬁcient to induce
poptosis.17,29,30
This study demonstrates the antifungal activity of the syn-
hetic compounds, terpinen-4-ol, tyrosol, and -lapachone
gainst the dimorphic fungi, C. posadasii and H. capsula-
um. It also highlights their role as potential leads for new
ntifungal agents for the treatment of histoplasmosis and coc-
idioidomycosis.
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